Key result
Mitral valve repair with CABG in patients with severe ischemic cardiomyopathy resulted in 0% early operative mortality and 14% late mortality at up to 3 years, with marked symptomatic improvement.
Why the study?
Does mitral valve repair combined with CABG improve survival and symptoms in patients with severe ischemic cardiomyopathy and mitral insufficiency?
Population
21 patients with severe ischemic mitral valve insufficiency and severe LV dysfunction, mean age 60 years…
Design
Case_series
Follow-up
up to 3 years
Authors
Loading...
Does not yet support routine mitral repair plus CABG in severe ischemic cardiomyopathy; leaves open survival benefit pending controlled trials.
Observational (n=21)
No
Does mitral valve repair combined with CABG improve survival and symptoms in patients with severe ischemic cardiomyopathy and mitral insufficiency?
Mitral valve repair with CABG can be performed safely in patients with severe ischemic cardiomyopathy, leading to marked symptomatic improvement despite no significant change in LV function.
Bitran et al. (2001) conducted an observational in Ischemic mitral valve insufficiency and severe LV dysfunction (n=21). Mitral valve repair and CABG was evaluated on Early operative mortality. Mitral valve repair with CABG in patients with severe ischemic cardiomyopathy resulted in 0% early operative mortality and 14% late mortality at up to 3 years, with marked symptomatic improvement.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: